Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration

@article{Byun2010PredictorsOR,
  title={Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration},
  author={Yeo Jue Byun and Sung Jun Lee and Hyoung Jun Koh},
  journal={Japanese Journal of Ophthalmology},
  year={2010},
  volume={54},
  pages={571-577}
}
To identify fluorescein angiography (FA) and optical coherence tomography (OCT) characteristics predicting responses to intravitreal bevacizumab therapy in patients with neovascular age-related macular degeneration (AMD). Results of 113 consecutive patients (113 eyes) treated with intravitreal bevacizumab injections for neovascular AMD were retrospectively reviewed. Patients were categorized into two groups according to visual acuity (VA) improvement 1 year after treatment: responders and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde • 2009

Ranibizumab for neovascular age-related macular degeneration.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists • 2008

Similar Papers

Loading similar papers…